Displaying items by tag: division of gynecologic oncology

A special presentation of the popular play at Virginia Samford Theatre will benefit ovarian cancer research at UAB.
Three-year, $2 million PCORI grant will give UAB caregivers an opportunity to develop surgical protocols that enhance coordination of care and improve quality of life for women with endometrial cancer.
Renowned UAB HPV expert Warner Huh says new nine-valent HPV vaccine has the potential to eradicate the majority of cervical cancer.
HPV testing alone is an effective alternative to current cervical cancer screening methods that use a Pap smear, or Pap smear-plus HPV test.

UAB faculty will give 25 presentations at ASCO scientific meeting; topics also include ovarian and breast cancers and AML, or acute myeloid leukemia.

UAB researcher presented several gynecological oncology studies to a national gathering of doctors.

UAB researcher explores use of antibody mechanism in platelet production that may reduce ovarian cancer progression.

A researcher in the UAB Comprehensive Cancer Center has been selected for the inaugural Ovarian Cancer Academy Award, part of the U.S. Department of Defense funding for cancer research. Assistant Professor Charles Landen, M.D., of the Division of Gynecologic Oncology, is one of seven early career investigators chosen for the grant. The award is $1.06 million from the Office of Congressionally Directed Medical Research.

Landen works to identify and characterize a subpopulation of ovarian cancer cells that have enhanced ability to survive chemotherapy and cause recurrence. Understanding this class of cells may lead to discoveries of key pathways than can be targeted with novel anti-cancer therapies.
Page 2 of 2